CLICK HERE FOR THOUSANDS OF FREE BLOGGER TEMPLATES »
Showing posts with label Self-Amplyfing. Show all posts
Showing posts with label Self-Amplyfing. Show all posts

Saturday, December 16, 2023

Are Self-Amplifying mRNA “Vaccines” Next-Generation Bioweapons?

Are Self-Amplifying mRNA “Vaccines” Next-Generation Bioweapons?

by | Dec 16, 2023 | Headline News | 0 comments

Share

Self-amplifying RNA (“saRNA”) is engineered to make more copies of itself once delivered into cells.   It encodes both the antigen of interest, for example, the COVID spike protein, and proteins that enable vaccine RNA replication. But are these just next-generation bioweapons designed to reduce the population?

According to a report by The Daily Exposé, a company called Meiji Seika Pharma released a statement on November 28th, announcing that it had been given approval by the Japanese Ministry of Health to manufacture and market its Kostaive sa-mRNA COVID vaccine also known as ARCT-154 (or in Vietnam, VBC-COV19-154).  Meiji Seika Pharma has entered into an exclusive partnership with CSL’s vaccine business, CSL Seqirus, one of the largest influenza vaccine providers in the world, to distribute the vaccine.

Japan has now become the first country in the world to approve these new self-amplifying mRNA (“sa-mRNA”) vaccines. With the approval of this “vaccine” secured in Japan, its developers are now seeking authorization in Europe; a regulatory decision is expected next year.

 As ZeroHedge reported, approval was given despite the Phase 3 trial, funded by the Japanese government, only testing the product on 838 people, with no control group.  Additionally, the results of the trial have not been published; the manuscript is “in preparation,” according to the Phase 3 study report. Much like the original COVID injections, the “vaccine” requires 2 doses, with the second being administered 28 days after the first, as well as booster injection/s for adults 18 years and older.

In the video below, Roman Balmakov explained more.

Facts Matter with Roman Balmakov: New Self-Replicating “sa-mRNA Vaccine” Approved For Mass Production, 13 December 2023 (10 mins).

The real question is whether or not these new “vaccines” can or will be used as bioweapons against the slave class.

It is very clear that these “vaccines” self-replicate, so how does the process stop? The simple answer is that it does not. If it is self-amplifying but not self-stopping, then we would expect an unceasing production of spike protein over time, causing continuous and cumulative damage until organ failure results. There does not seem to be any internal control limiting the production of the spike protein. This would mean that the effect of self-amplifying RNA is equivalent to taking repeated doses indefinitely!

That means, if the ruling class can convince the general public to take these types of shots, they could use them as a bioweapon and let them slowly take out those injected.

Source:  https://www.shtfplan.com/headline-news/are-self-amplifying-mrna-vaccines-next-generation-bioweapons

 

Monday, December 11, 2023

Japan Approves World’s First ‘Self-Amplifying’ mRNA CV Vaccine Without Published Efficacy or Safety Data

 

Japan Approves World’s First ‘Self-Amplifying’ mRNA COVID-19 Vaccine Without Published Efficacy or Safety Data

The latest iteration of the mRNA vaccine is even more potent than the present version, as it generates more spike proteins in the human body.
Japan Approves World’s First ‘Self-Amplifying’ mRNA COVID-19 Vaccine Without Published Efficacy or Safety Data
Rendering of SARS-CoV-2 spike proteins binding to ACE2 receptors. (Shutterstock)
Naveen Athrappully
12/8/2023
Updated:
12/8/2023

Japan has approved the world’s first self-amplifying mRNA (sa-mRNA) COVID-19 vaccine, although the manufacturer has not published safety or efficacy data for the shot.

Tokyo-based Meiji Seika Pharma received approval for manufacturing and marketing its Kostaive sa-mRNA COVID-19 vaccine, the company announced in a Nov. 28 press release. The mRNA in the vaccine is designed to self-amplify when delivered into cells, which generates a “strong immune response and the potential for extended duration of protection.” The vaccine is intended for primary immunization (2 doses) as well as booster immunization in adults. Kostaive is the "world's first approved product applying self-amplifying mRNA technology," according to the press release.

Both mRNA and sa-mRNA are RNA vaccines that use a virus’ genetic code against it. When an mRNA vaccine is injected into an individual, the mRNA instructs cells to make a specific protein and thus stimulates immune response. An sa-mRNA vaccine takes this concept further by making multiple mRNA copies, which ends up generating more spike protein.

Toby Young, general secretary of the Free Speech Union, a public interest group, pointed out in a Nov. 30 X post that the sa-mRNA vaccine was approved in Japan “despite only testing it on 800 people, no control group and only checking antibody levels not infection rates. Medicine regulation died with Covid.”

Read more 

Source:   https://www.theepochtimes.com/article/japan-approves-worlds-first-self-amplifying-mrna-covid-19-vaccine-without-published-efficacy